Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1976 1
1977 1
1979 2
1986 4
1992 1
1993 4
1994 1
1996 1
1998 4
1999 1
2000 2
2001 5
2002 1
2003 3
2004 1
2005 3
2006 4
2007 5
2008 3
2009 7
2010 5
2011 9
2012 1
2013 4
2014 4
2015 4
2016 10
2017 11
2018 17
2019 19
2020 15
2021 13
2022 21
2023 26
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
La priorización de la investigación es un ejercicio ético: lecciones del Foro Global de Bioética en la Investigación para la Región de las Américas.
Saenz C, Carracedo S, Caballero C, Hurtado C, Leite Ribeiro A, Luna F, Ortiz Z, Palmero A, Peralta G, Ponce Testino R, Reveiz L, Sisa I. Saenz C, et al. Among authors: caballero c. Rev Panam Salud Publica. 2024 Mar 8;48:e26. doi: 10.26633/RPSP.2024.26. eCollection 2024. Rev Panam Salud Publica. 2024. PMID: 38464874 Free PMC article. Spanish. No abstract available.
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Aftimos P, Oliveira M, Irrthum A, Fumagalli D, Sotiriou C, Gal-Yam EN, Robson ME, Ndozeng J, Di Leo A, Ciruelos EM, de Azambuja E, Viale G, Scheepers ED, Curigliano G, Bliss JM, Reis-Filho JS, Colleoni M, Balic M, Cardoso F, Albanell J, Duhem C, Marreaud S, Romagnoli D, Rojas B, Gombos A, Wildiers H, Guerrero-Zotano A, Hall P, Bonetti A, Larsson KF, Degiorgis M, Khodaverdi S, Greil R, Sverrisdóttir Á, Paoli M, Seyll E, Loibl S, Linderholm B, Zoppoli G, Davidson NE, Johannsson OT, Bedard PL, Loi S, Knox S, Cameron DA, Harbeck N, Montoya ML, Brandão M, Vingiani A, Caballero C, Hilbers FS, Yates LR, Benelli M, Venet D, Piccart MJ. Aftimos P, et al. Among authors: caballero c. Cancer Discov. 2021 Nov;11(11):2796-2811. doi: 10.1158/2159-8290.CD-20-1647. Epub 2021 Jun 28. Cancer Discov. 2021. PMID: 34183353 Free PMC article.
[Obstructive Sleep Apnea].
Roncero A, Castro S, Herrero J, Romero S, Caballero C, Rodriguez P. Roncero A, et al. Among authors: caballero c. Open Respir Arch. 2022 Jun 9;4(3):100185. doi: 10.1016/j.opresp.2022.100185. eCollection 2022 Jul-Sep. Open Respir Arch. 2022. PMID: 37496584 Free PMC article. Spanish.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, Vergote I, Parma G, Nøttrup TJ, Lebreton C, Fasching PA, Pisano C, Manso L, Bourgeois H, Runnebaum I, Zamagni C, Hardy-Bessard AC, Schnelzer A, Fabbro M, Schmalfeldt B, Berton D, Belau A, Lotz JP, Gropp-Meier M, Gladieff L, Lück HJ, Abadie-Lacourtoisie S, Pujade-Lauraine E, Ray-Coquard I. Lorusso D, et al. Among authors: caballero c. Int J Gynecol Cancer. 2024 Apr 1;34(4):550-558. doi: 10.1136/ijgc-2023-004995. Int J Gynecol Cancer. 2024. PMID: 38129136 Free PMC article. Clinical Trial.
Comprehensive Review of Fluorescence Applications in Gynecology.
Polom J, Kalinowski L, Diana M, Chand M, Caballero C, Sawicki S, Polom K. Polom J, et al. Among authors: caballero c. J Clin Med. 2021 Sep 25;10(19):4387. doi: 10.3390/jcm10194387. J Clin Med. 2021. PMID: 34640405 Free PMC article. Review.
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells.
Hassin O, Sernik M, Seligman A, Vogel FCE, Wellenstein MD, Smollich J, Halperin C, Pirona AC, Toledano LN, Caballero CD, Schlicker L, Salame TM, Sarusi Portuguez A, Aylon Y, Scherz-Shouval R, Geiger T, de Visser KE, Schulze A, Oren M. Hassin O, et al. Among authors: caballero cd. Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2311460120. doi: 10.1073/pnas.2311460120. Epub 2023 Dec 21. Proc Natl Acad Sci U S A. 2023. PMID: 38127986 Free PMC article.
This is a call to oncologists for action.
Micó C, Berrocal A, Blasco A, Caballero C, Iranzo V, Lobo M, Camps C. Micó C, et al. Among authors: caballero c. Clin Transl Oncol. 2018 Dec;20(12):1493-1501. doi: 10.1007/s12094-018-1887-3. Epub 2018 May 23. Clin Transl Oncol. 2018. PMID: 29796999 Review.
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
de Azambuja E, Agostinetto E, Procter M, Eiger D, Pondé N, Guillaume S, Parlier D, Lambertini M, Desmet A, Caballero C, Aguila C, Jerusalem G, Walshe JM, Frank E, Bines J, Loibl S, Piccart-Gebhart M, Ewer MS, Dent S, Plummer C, Suter T; APHINITY Steering Committee and Investigators. de Azambuja E, et al. Among authors: caballero c. ESMO Open. 2023 Feb;8(1):100772. doi: 10.1016/j.esmoop.2022.100772. Epub 2023 Jan 19. ESMO Open. 2023. PMID: 36681013 Free PMC article. Clinical Trial.
206 results